The results of a tumorigenicity test using an orthotopic xenotransplant BC model indicated that the self-stimulation of natural killer group 2D receptor (NKG2D) could promote BC by increasing angiogenesis and promoting tumour growth, intravasation, and dissemination [27]. The gene discussed is KLRK1; the disease is breast cancer.